4th Quarter & Final Results - Part 2

AstraZeneca PLC 24 February 2000 PART 2 Consolidated Profit & Loss Account For Ongoing Operations Before Exceptional Items 4th 4th Quarter Quarter Year Year 1999 1998 1999 1998 USDm USDm USDm USDm ------------------------------------ ----- ----- ----- ----- Sales 3,916 3,692 15,134 11,318 Cost of sales (1,045) (939) (4,087) (2,651) Distribution costs (57) (57) (230) (201) Research and development (711) (632) (2,472) (2,103) Selling, general and administrative expenses (1,349) (1,319) (4,915) (3,936) Other operating income 42 61 140 119 ------------------------------------ ----- ----- ----- ----- Group operating profit 796 806 3,570 2,546 Share of joint ventures' and associates' operating profits (14) (15) (10) 534 Net interest 20 6 (4) 47 ------------------------------------ ----- ----- ----- ----- Profit on ordinary activities before taxation 802 797 3,556 3,127 Taxation (240) (212) (1,048) (903) ------------------------------------ ----- ----- ----- ----- Profit on ordinary activities after taxation 562 585 2,508 2,224 Attributable to minorities 2 (2) - (3) ------------------------------------ ----- ----- ----- ----- Net profit for the period 564 583 2,508 2,221 ------------------------------------ ----- ----- ----- ----- Earnings per Ordinary Share USD0.32 USD0.33 USD1.41 USD1.25 Diluted earnings per Ordinary Share USD0.32 USD0.33 USD1.41 USD1.24 ------------------------------------ ----- ----- ----- ----- Weighted average number of Ordinary Shares in issue (millions) 1,777 1,779 1,776 1,779 ------------------------------------ ----- ----- ----- ----- Diluted average number of Ordinary Shares in issue (millions) 1,779 1,783 1,779 1,783 ------------------------------------ ----- ----- ----- ----- Statutory Consolidated Profit and Loss Accounts including operations to be discontinued, discontinued operations and exceptional items for the years ended 31 December 1999 and 1998 are provided on pages 13 and 14, respectively. For the year ended 31 December 1998, a Pro Forma Consolidated Profit and Loss Account is provided on Page 15. Consolidated Profit and Loss Account Continuing Operations Discont- Total inued oper- ations ----------------------- Oper- ations Ongoing to be Except- oper- discon- ional ations tinued items For the year ended 31 December 1999 USDm USDm USDm USDm USDm ----------------------------------- ----- ----- ----- ----- ----- Sales 15,134 2,657 - 654 18,445 Cost of sales (4,087) (1,510) (37) (403) (6,037) Distribution costs (230) (84) - (29) (343) Research and development (2,472) (297) (110) (44) (2,923) Selling, general and administrative expenses (4,915) (545) (1,015) (110) (6,585) Other operating income 140 46 - 3 189 ----------------------------------- ----- ----- ----- ----- ----- Group operating profit 3,570 267 (1,162) 71 2,746 Share of joint ventures' and associates' operating profits (10) 2 - 1 (7) Profits less losses on sale and closure of operations - - - 237 237 Merger costs - - (1,013) - (1,013) Net interest (4) - - - (4) ----------------------------------- ----- ----- ----- ----- ----- Profit on ordinary activities before taxation 3,556 269 (2,175) 309 1,959 Taxation (1,048) (93) 448 (122) (815) ----------------------------------- ----- ----- ----- ----- ----- Profit on ordinary activities after taxation 2,508 176 (1,727) 187 1,144 Attributable to minorities - (1) - - (1) ----------------------------------- ----- ----- ----- ----- ----- Net profit for the financial year 2,508 175 (1,727) 187 1,143 Dividends to Shareholders (1,242) ----------------------------------- ----- ----- ----- ----- ----- Loss retained for the financial year (99) ----------------------------------- ----- ----- ----- ----- ----- Earnings per Ordinary Share before exceptional items USD1.41 USD0.10 - USD0.03 USD1.54 Earnings per Ordinary Share USD1.41 USD0.10(USD0.97)USD0.10 USD0.64 Diluted earnings per Ordinary Share USD1.41 USD0.10(USD0.97)USD0.10 USD0.64 ----------------------------------- ----- ----- ----- ----- ----- Weighted average number of Ordinary Shares in issue (millions) 1,776 ----------------------------------- ----- Diluted average number of Ordinary Shares in issue (millions) 1,779 ----------------------------------- ----- Consolidated Profit and Loss Account Continuing Operations Discon- Total -inued oper- ations ----------------------- Oper- ations Ongoing to be Except- oper- discon- ional ations tinued items For the year ended 31 December 1998 USDm USDm USDm USDm USDm ----------------------------------- ----- ----- ----- ----- ----- Sales 11,318 2,790 - 1,294 15,402 Cost of sales (2,651) (1,511) - (799) (4,961) Distribution costs (201) (107) - (59) (367) Research and development (2,103) (286) - (84) (2,473) Selling, general and administrative expenses (3,936) (588) (72) (216) (4,812) Other operating income 119 61 163 10 353 ----------------------------------- ----- ----- ----- ----- ----- Group operating profit 2,546 359 91 146 3,142 Share of joint ventures' and associates' operating profits 534 1 - 4 539 Profits less losses on sale and closure of operations - - - (46) (46) Profits on sale of fixed assets - - 17 - 17 Net interest 47 - - - 47 ----------------------------------- ----- ----- ----- ----- ----- Profit on ordinary activities before taxation 3,127 360 108 104 3,699 Taxation (903) (126) (16) (41) (1,086) ----------------------------------- ----- ----- ----- ----- ----- Profit on ordinary activities after taxation 2,224 234 92 63 2,613 Attributable to minorities (3) 1 - - (2) ----------------------------------- ----- ----- ----- ----- ----- Net profit for the financial year 2,221 235 92 63 2,611 Dividends to Shareholders (1,061) ----------------------------------- ----- ----- ----- ----- ----- Profit retained for the financial year 1,550 ----------------------------------- ----- ----- ----- ----- ----- Earnings per Ordinary Share before exceptional items USD1.25 USD0.13 - USD0.06 USD1.44 Earnings per Ordinary Share USD1.25 USD0.13 USD0.05 USD0.04 USD1.47 Diluted earnings per Ordinary Share USD1.24 USD0.13 USD0.05 USD0.04 USD1.46 ----------------------------------- ----- ----- ----- ----- ----- Weighted average number of Ordinary Shares in issue (millions) 1,779 ----------------------------------- ----- Diluted average number of Ordinary Shares in issue (millions) 1,783 ----------------------------------- ----- Pro Forma* Consolidated Profit and Loss Account Continuing Operations Discon- Total tinued oper- ations ----------------------- Oper- ations Ongoing to be Except- oper- discon- ional ations tinued items For the year ended 31 December 1998 USDm USDm USDm USDm USDm ----------------------------------- ----- ----- ----- ----- ----- Sales 13,033 2,790 - 1,294 17,117 Cost of sales (3,302) (1,511) - (799) (5,612) Distribution costs (209) (107) - (59) (375) Research and development (2,181) (286) - (84) (2,551) Selling, general and administrative expenses (4,458) (588) (72) (216) (5,334) Other operating income 119 61 163 10 353 ----------------------------------- ----- ----- ----- ----- ----- Group operating profit 3,002 359 91 146 3,598 Share of joint ventures' and associates' operating profits (2) 1 - 4 3 Profits less losses on sale and closure of operations - - - (46) (46) Profits on sale of fixed assets - - 17 - 17 Net interest (60) - - - (60) ----------------------------------- ----- ----- ----- ----- ----- Profit on ordinary activities before taxation 2,940 360 108 104 3,512 Taxation (856) (126) (16) (41) (1,039) ----------------------------------- ----- ----- ----- ----- ----- Profit on ordinary activities after taxation 2,084 234 92 63 2,473 Attributable to minorities (3) 1 - - (2) ----------------------------------- ----- ----- ----- ----- ----- Net profit for the financial year 2,081 235 92 63 2,471 Dividends to Shareholders (1,061) ----------------------------------- ----- ----- ----- ----- ----- Profit retained for the financial year 1,410 ----------------------------------- ----- ----- ----- ----- ----- Earnings per Ordinary Share before exceptional items USD1.17 USD0.13 - USD0.06 USD1.36 Earnings per Ordinary Share USD1.17 USD0.13 USD0.05 USD0.04 USD1.39 Diluted earnings per Ordinary Share USD1.17 USD0.13 USD0.05 USD0.04 USD1.39 ----------------------------------- ----- ----- ----- ----- ----- Weighted average number of Ordinary Shares in issue (millions) 1,779 ----------------------------------- ----- Diluted average number of Ordinary Shares in issue (millions) 1,783 ----------------------------------- ----- * See Basis of Pro Forma Figures described in Note 2. Consolidated Balance Sheet 1999 1998 At 31 December USDm USDm ----------------------------------------- ----- ----- Fixed assets Tangible fixed assets 5,981 6,281 Goodwill and intangible assets 3,736 2,440 Fixed asset investments 185 353 ----------------------------------------- ----- ----- 9,902 9,074 ----------------------------------------- ----- ----- Current assets Stocks 2,156 2,029 Debtors 4,470 3,963 Cash and short-term investments 3,288 3,412 ----------------------------------------- ----- ----- 9,914 9,404 ----------------------------------------- ----- ----- Total assets 19,816 18,478 ----------------------------------------- ----- ----- Creditors due within one year Short-term borrowings and current instalments of loans (378) (377) Other creditors (6,641) (5,273) ----------------------------------------- ----- ----- (7,019) (5,650) Net current assets 2,895 3,754 ----------------------------------------- ----- ----- Total assets less current liabilities 12,797 12,828 ----------------------------------------- ----- ----- Creditors due after more than one year Loans (739) (761) Other creditors (463) (40) Provisions for liabilities and charges (1,253) (1,045) ----------------------------------------- ----- ----- (2,455) (1,846) ----------------------------------------- ----- ----- Net assets 10,342 10,982 ----------------------------------------- ----- ----- Capital and reserves Shareholders' funds - equity interests 10,302 10,929 Minority equity interests 40 53 ----------------------------------------- ----- ----- Shareholders' funds and minority interests 10,342 10,982 ----------------------------------------- ----- ----- Consolidated Cash Flow Statement 4th 4th Quarter Quarter Year Year 1999 1998 1999 1998 USDm USDm USDm USDm ------------------------------------ ----- ----- ----- ----- Cash flow from operating activities Operating profit before exceptional items 789 841 3,908 3,051 Depreciation 204 186 756 680 Amortisation 84 51 313 141 Decrease/(increase) in working capital 356 233 (219) 77 Other non-cash movements 27 7 (59) (132) ------------------------------------ ----- ----- ----- ----- Net cash inflow from operating activities before exceptional items 1,460 1,318 4,699 3,817 (Outflow)/inflow related to exceptional items (475) 83 (1,586) 15 ------------------------------------ ----- ----- ----- ----- Net cash inflow from operating activities 985 1,401 3,113 3,832 ------------------------------------ ----- ----- ----- ----- Dividends received from joint ventures and associates - - 3 262 ------------------------------------ ----- ----- ----- ----- Returns on investments and servicing of finance 57 22 29 103 ------------------------------------ ----- ----- ----- ----- Tax paid (335) (255) (1,020) (775) ------------------------------------ ----- ----- ----- ----- Capital expenditure and financial investment Net cash expenditure on fixed assets (562) (347) (2,725) (1,351) New fixed asset investments - - (6) (18) ------------------------------------ ----- ----- ----- ----- (562) (347) (2,731) (1,369) ------------------------------------ ----- ----- ----- ----- Acquisitions and disposals 31 25 1,978 (2,013) ------------------------------------ ----- ----- ----- ----- Equity dividends paid to Shareholders (416) (223) (1,216) (995) ------------------------------------ ----- ----- ----- ----- Net cash (outflow)/inflow before management of liquid resources and financing (240) 623 156 (955) ------------------------------------ ----- ----- ----- ----- Management of liquid resources Movement in short-term investments and fixed deposits (net) (254) 974 ----------------------------------------- ----- ----- Financing (182) (205) ----------------------------------------- ----- ----- Decrease in cash in the period (280) (186) ----------------------------------------- ----- ----- Statement of Total Recognised Gains and Losses 1999 1998 For the year ended 31 December USDm USDm ----------------------------------------- ----- ----- Net profit for the financial year 1,143 2,611 Exchange adjustments on net assets (740) (178) Translation differences on foreign currency borrowings 132 (7) Tax on translation differences on foreign currency borrowings (22) 2 Other movements - 2 ----------------------------------------- ----- ----- Total recognised gains and losses for the financial year 513 2,430 ----------------------------------------- ----- ----- MORE TO FOLLOW QRRIFFFFFEIVFII

Companies

AstraZeneca (AZN)
UK 100

Latest directors dealings